Cover Image

Major reduction in occurrence of anti‐c and anti‐E in pregnancy after more than 10 years of preventive matched transfusion with most benefit for c‐matching

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Jessie S. Luken, Claudia C. Folman, Johan H. Meekers, Michael V. Lukens, C. Ellen van der Schoot, Masja de Haas
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	British Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost‐effectiveness of cEK ‐preventive matched transfusion strategies for female transfusion recipients to prevent haemolytic disease of the foetus and newborn in the Dutch healthcare setting
by: Jessie S. Luken, et al.
Published: (2026)

Blood group genotype matching for transfusion
by: Connie M. Westhoff, et al.
Published: (2024)

Challenging the dogma: Red blood cell‐directed autoimmunity as risk factor for red blood cell alloimmunisation after blood transfusion
by: Josine A. Oud, et al.
Published: (2024)

Successful management of refractory immune‐mediated thrombotic thrombocytopenic purpura during pregnancy and delivery using the anti‐VWF nanobody caplacizumab
by: Roman R. Schimmer, et al.
Published: (2024)

Lamotrigine and anti‐seizure medications in HLH: A systematic review
by: Yaswanta K. Gummadi, et al.
Published: (2025)

To err is human … so how can we prevent all ABO‐incompatible transfusions?
by: Nancy M. Dunbar, et al.
Published: (2024)

Outcome of T‐cell/histiocyte‐rich large B‐cell lymphoma—A Danish nationwide matched cohort study
by: Peter Brændstrup, et al.
Published: (2025)

Contextualizing prophylactic red blood cell antigen matching in the lifelong care of sickle cell disease and thalassaemia patients
by: Eric A. Gehrie, et al.
Published: (2024)

Real‐world experience with CPX ‐351 for secondary acute myeloid leukaemia: Comparison with FLAG ‐ IDA in a propensity score matching analysis
by: Maria Agustina Perusini, et al.
Published: (2025)

Cardiotoxicity in patients with acute myeloid leukaemia following anthracycline‐containing chemotherapy: A population‐based matched cohort study
by: Rikke Hedegaard Jensen, et al.
Published: (2025)

Longitudinal plasma proteomics in romiplostim‐treated patients with immune thrombocytopenia
by: Vivianne S. Nelson, et al.
Published: (2025)

The role of chimeric antigen receptor T cells targeting more than one antigen in the treatment of B‐cell malignancies
by: Helena Brillembourg, et al.
Published: (2024)

The impact of letermovir prophylaxis in matched sibling donor haematopoietic stem cell transplantation: Selecting the appropriate population for optimal prophylactic therapy
by: Sisi Zhen, et al.
Published: (2025)

Low‐dose iron chelation as anti‐oxidative therapy in patients with sickle cell disease: A single‐centre pilot study
by: Aafke E. Gaartman, et al.
Published: (2024)

Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation?
by: A. Vijenthira, et al.
Published: (2024)

Impact of age and time since diagnosis on thrombosis risk in myeloproliferative neoplasm patients: A nationwide register‐based matched cohort study
by: Nurgul Batyrbekova, et al.
Published: (2025)

CD71+ erythroid cells promote multiple myeloma progression and impair anti‐bacterial immune response
by: K. Czubak, et al.
Published: (2024)

Rituximab with alkylating agent in anti‐myelin‐associated glycoprotein neuropathy: A retrospective study of 26 cases
by: D. Elessa, et al.
Published: (2024)

Clinical decision support systems in transfusion
by: Louise H. Strickland, et al.
Published: (2026)

Increased donor inhibitory KIR are associated with reduced GVHD and improved survival following HLA‐matched unrelated donor HCT in paediatric acute leukaemia
by: Elizabeth Krieger, et al.
Published: (2024)

Improved early transplant outcomes with reduced‐dose PTCy and low‐dose ATG in matched unrelated donor allogeneic transplantation for acute myeloid leukaemia
by: Nihar Desai, et al.
Published: (2026)

Successful autologous haematopoietic stem cell transplantation in a refractory anti‐myelin‐associated glycoprotein antibody neuropathy
by: Fanny Urbain, et al.
Published: (2024)

TTP and pregnancy
by: P. Gounder, et al.
Published: (2024)

Phase II trial of posaconazole prophylaxis during anti‐thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome
by: Dong Hyun Kim, et al.
Published: (2024)

Successful combined anti‐CD19 immunotherapy of relapsed acute lymphoblastic leukaemia in a child with Nijmegen breakage syndrome
by: A. Oszer, et al.
Published: (2025)

Type I interferon as a pre‐lupus marker in anti‐nuclear antibody‐associated childhood immune thrombocytopenic purpura
by: Jérôme Granel, et al.
Published: (2025)

Thrombocytopenia 4 (THC4): Six novel families with mutations of the cytochrome c gene
by: Antonio Marzollo, et al.
Published: (2024)

Red cell specifications for blood group matching in patients with haemoglobinopathies: An updated systematic review and clinical practice guideline from the International Collaboration for Transfusion Medicine Guidelines
by: Julia Wolf, et al.
Published: (2024)

Erratum to: The HMG‐CoA inhibitor, simvastatin, triggers in vitro anti‐tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia
Published: (2024)

Geranylgeranyl transferase‐1 inhibitor GGTI ‐2417 enhances the anti‐tumour efficacy of histone deacetylase inhibitors in different T‐cell lymphoma lines
by: Xiaoyan Hu, et al.
Published: (2025)

Equal outcomes after human leukocyte antigen‐matched unrelated versus sibling donor transplants—Results of the AML SCT ‐ BFM 2007 trial and consecutive ‘real‐world routine’
by: Martin G. Sauer, et al.
Published: (2026)

Iron overload and morbidities in Chinese with non‐transfusion‐dependent thalassaemia
by: Wing‐yan Leung, et al.
Published: (2025)

Deregulated megakaryocytic maturation, mitochondrial function and inflammatory signalling in CYCS (c.292T>C) ‐related thrombocytopenia
by: Konstantina Giavi, et al.
Published: (2026)

Structural similarity between CD38 and the Duffy antigen as a potential mechanism of attenuated anti‐Fy antibody reactivity with soluble CD38
by: Yohei Sakai, et al.
Published: (2026)

Safety and efficacy of anti‐coagulation for primary and secondary venous thromboembolism prophylaxis in hospitalized adolescents and young adults with sickle cell disease: An institutional experience
by: Vilmarie Rodriguez, et al.
Published: (2026)

Immune thrombocytopenia (ITP) in pregnancy
by: James B. Bussel, et al.
Published: (2024)

The impact of matched and mismatched donor–recipient genotypes for MDR1 polymorphisms (G2677TA, C1236T and C3435T) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation
by: Ziwen Duan, et al.
Published: (2024)

Interstitial 11q Deletions and Terminal 11q Duplications Cause a Bleeding Tendency due to Platelet Dysfunction That Is Similar to 11q Deletions Causing Jacobsen Syndrome
by: Elise J. Huisman, et al.
Published: (2025)

Predictors of renal response in AL amyloidosis following anti‐plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotype
by: Matthew J. Rees, et al.
Published: (2026)

Outcomes with low dose anti‐thymocyte globulin based graft versus host disease prophylaxis after mismatched unrelated donor allogeneic hematopoietic cell transplantation
by: Hafsah Chalchal, et al.
Published: (2024)